Lead Product(s): Lurbinectedin
Therapeutic Area: Oncology Product Name: Zepzelca
Highest Development Status: Undisclosed Product Type: Small molecule
Partner/Sponsor/Collaborator: Stand Up To Cancer
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration August 10, 2021
The collaboration will provide SU2C-funded researchers access to two Jazz molecules and funds to support one or more research projects over three years. One of the projects would help explore clinical use of lurbinectedin in rare and hard to treat pediatric solid tumors.